Basal cell carcinoma of skin of nose. C44.311 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM C44.311 became effective on October 1, 2018.
Basal cell carcinoma of skin of other and unspecified parts of face. Short description: Bsl cel skn face NEC/NOS. ICD-9-CM 173.31 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 173.31 should only be used for claims with a date of service on or before September 30, 2015.
Basal cell carcinoma of skin, site unspecified Short description: Basal cell ca skin NOS. ICD-9-CM 173.91 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 173.91 should only be used for claims with a date of service on or before September 30, 2015.
Malignant neoplasm of nasal cavities. Short description: Mal neo nasal cavities. ICD-9-CM 160.0 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 160.0 should only be used for claims with a date of …
Cancer of the skin, trunk, basal cell. 173.50. ICD9Data.com. 173.52. ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 173.51 is one of thousands of ICD-9-CM codes used in healthcare.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...